| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |